©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
Stat5 as a Target for Regulation by Extracellular Matrix (*)

(Received for publication, July 19, 1995)

Charles H. Streuli (1)(§) Gwynneth M. Edwards (1)(¶) Marc Delcommenne (1) C. Bruce A. Whitelaw (2) Thomas G. Burdon (2)(**) Chris Schindler (3) Christine J. Watson (§§)

From the  (1)School of Biological Sciences, University of Manchester, Manchester M13 9PT, United Kingdom, (2)Roslin Institute (Edinburgh) Roslin, Midlothian EH25 9PS, United Kingdom, and the (3)Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, New York 10032

ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES

ABSTRACT

Transcription of tissue-specific genes in mammary gland requires signals from both prolactin and basement membrane. Here we address the mechanism by which this specialized extracellular matrix regulates transcription. Using mammary cell cultures derived from transgenic mice harboring the ovine beta-lactoglobulin gene, we show that either a basement membrane extract, or purified laminin-1, induced high levels of beta-lactoglobulin synthesis. It is known that prolactin signals through Stat5 (signal transducer and activator of transcription). This transcription factor interacts with -interferon activation site-related motifs within the beta-lactoglobulin promoter, which we show are required for matrix dependence of beta-lactoglobulin expression. The DNA binding activity of Stat5 was present only in extracts of mammary cells cultured on basement membrane, indicating that the activation state of Stat5 is regulated by the type of substratum the cell encounters. Thus, basement membrane controls transcription of milk protein genes through the Stat5-mediated prolactin signaling pathway, providing a molecular explanation for previous studies implicating extracellular matrix in the control of mammary differentiation.


INTRODUCTION

Cell-matrix interactions are critical for regulating the phenotype of many cells. In mammary gland, basement membrane is necessary for the prolactin-mediated control of lactation(1, 2, 3) . However, the mechanism by which extracellular matrix (ECM) (^1)influences differentiation in mammary epithelial cells has not been elucidated. We have shown previously that functional beta(1) integrins are required for mammary differentiation (4) and that the basement membrane component laminin-1 directs milk protein gene transcription coordinately with prolactin(5) .

The prolactin pathway is driven through the protein tyrosine kinase Jak2 (6, 7, 8, 9, 10) and one of its substrates, the transcription factor Stat5 (11, 12) . Stat factors associate with cytokine receptors following ligand binding and subsequently become phosphorylated by receptor-associated Jaks. They then dimerize and translocate to the nucleus where they bind specific DNA sequence motifs, thus contributing to transcriptional activation(13, 14, 15) .

In this paper we examine whether an element of the prolactin signaling pathway is modulated directly by cell-matrix interactions, thereby mediating the ECM control of transcription. Using primary and first passage cultures of mammary epithelial cells, we demonstrate that the activity of the promoter for the milk protein beta-lactoglobulin (BLG) is dependent on basement membrane and that Stat5 recognition sites within this promoter are required for transcription. Moreover, we show that the ability of Stat5 to bind its cognate DNA sequence within the BLG promoter requires cell interactions with both basement membrane and prolactin. Thus, matrix and cytokine signals converge on a single pathway.

Our data demonstrate, for the first time, that the activity of a Stat transcription factor is a target for regulation by ECM. This establishes a novel signaling route that is subject to control by cell-matrix interactions, in addition to those already described involving mitogen-activated protein kinases(16, 17) , insulin receptor substrate-1(18) , and Ras(17) .


MATERIALS AND METHODS

Substrata

Collagen I-coated dishes were prepared by incubating plates overnight at 4 °C with rat tail collagen in PBS to give a coating density of 8 µg/cm^2. The plates were washed twice with cold PBS and once with medium before use. EHS matrix was prepared from the Engelbreth-Holm-Swarm tumor and used as a substratum as described(2, 4, 5) . In some experiments, cells were seeded onto glass coverslips precoated with 3 µg/cm^2 vitronectin (Sigma) before being overlaid with 200 µg/ml of either complete EHS matrix or purified laminin-1 (19) diluted into differentiation medium(5) .

Cell Culture

Mammary epithelial cells were isolated from 14.5-18.5-day pregnant transgenic mice (BLG.SX/45, BLGDeltaDp/39, BLGDeltaDp/46(20) , BcDeltaDp/188, (^2)and BLG-SAA (22) (Fig. 1)) or normal ICR mice and established in culture as described(2, 4, 5, 23) . Most experiments were done with primary mammary epithelial cultures. Cells were plated on tissue culture plastic or on dishes coated with either a thin layer of collagen I or with EHS matrix at a density of 2.5-5 times 10^5 cells/cm^2 for 48-72 h in growth medium, F12 (Sigma) containing 10% heat-inactivated fetal calf serum (Advanced Protein Products, Brierley Hill, UK), 10 ng/ml epidermal growth factor (Promega Corp., Southampton, UK), 1 mg/ml fetuin, 5 µg/ml insulin, and 1 µg/ml hydrocortisone (Sigma). The cultures were washed extensively, and the medium was changed to differentiation medium (DMEM/F12 (Life Technologies Ltd., Paisley, Scotland) containing 5 µg/ml insulin, 1 µg/ml hydrocortisone, and 3 µg/ml prolactin (Sigma). In some experiments, first passage mammary epithelial cells were used. In this case, primary cells were grown on dishes coated with collagen I in growth medium for 48-72 h as described above and then trypsinized to single cell suspensions and plated at 1 times 10^5 cells/cm^2 on appropriate substrata in DMEM/F12 medium containing 10% heat-inactivated fetal calf serum, 10 ng/ml epidermal growth factor, 5 µg/ml insulin, and 1 µg/ml hydrocortisone for 24-48 h before changing the medium to differentiation medium(5) . Depending on the experiment, cells were harvested up to 4 days later. Under these conditions, both primary and first passage cells cultured on EHS matrix form lactational alveoli that undergo functional (1, 2, 4, 5) differentiation.


Figure 1: Structure of the BLG gene and constructs used for generating transgenic mice. The structure of the ovine BLG gene is shown at the top. BLG.SX/45 contains the full gene including a 4.3-kb 5`-flanking sequence and 1.9-kb 3`-flanking sequence (20) . The 5`-promoter region was truncated to 406 bp in BLGDeltaDp/46 and BLGDeltaDp/39(20) . This region of the promoter contains three nucleotide sequences that are bound by Stat5. Sites 1-3 are named, respectively, A1, A3S, and STM, and the relative binding affinities of Stat5 to these sites are 1:8:44(26) . Dinucleotides were mutated within each of these factor-binding regions to generate BLG-SAA(22) . The wild type 406-bp proximal promoter was also used to drive expression of CAT in BCDeltaDp/188.^2



Protein Analysis

Cultures were washed 3 times with methionine-free DMEM/F12 medium containing appropriate hormones, and after 30-60 min this was replaced with similar medium containing 0.25 mCi/ml [S]methionine (TranS-label, ICN Biomedicals Ltd., High Wycombe, UK) for 25-240 min. To harvest cell proteins, cultures were washed 3 times with warm medium, chilled on ice, and extracted with radioimmune precipitation buffer containing proteinase inhibitors, and the detergent-insoluble proteins were cleared by centrifugation, all as described(5, 23) . Metabolic incorporation into newly made protein was measured by precipitation with trichloroacetic acid, and aliquots representing equal numbers of precipitable counts were separated on 15% polyacrylamide gels under reducing conditions. Mouse milk proteins were precipitated with a rabbit anti-mouse milk antiserum followed by Protein A-Sepharose (Zymed Laboratories Inc., South San Francisco, CA) before separation by SDS-PAGE(5, 23) . Either gels were analyzed by fluorography or digitized images were obtained from dried gels using storage phosphor imaging plates and a Fujix Bas 2000 bioimaging analyzer (Fuji Photo Film Co. Ltd., Tokyo, Japan). The levels of beta-casein and BLG in whole cell lysates were quantitated with Fuji software and normalized to the total number of counts on each lane of the polyacrylamide gel. No proteins corresponding to BLG were detected in cultures from non-transgenic mice or from BCDeltaDp/188 transgenic mice. To confirm the identity of the protein designated BLG in cultures from BLG.SX/45, BLGDeltaDp/39, BLGDeltaDp/46, and BLG-SAA transgenic mice, immune precipitations were performed with a rabbit anti-ovine BLG antiserum.

CAT Assays

To measure chloramphenicol acetyltransferase (CAT) enzyme levels as an indicator of BLG promoter activity, primary or first passage cells derived from BCDeltaDp/188 transgenic mice were harvested, the extracts normalized, and the CAT activity measured, all as described(24, 25) . Cells cultured on EHS matrix were washed twice with Puck's saline, harvested by treatment with 1% dispase (Boehringer Mannheim Ltd., Lewes, UK) for 30 min at 37 °C, washed to remove dispase, and suspended in 0.25 M Tris-Cl, pH 7.8. Cells cultured on plastic were detached with trypsin-EDTA, washed three times with PBS, and suspended in 0.25 M Tris-Cl, pH 7.8. A cell extract was prepared by three cycles of freeze-thawing followed by centrifugation at 14,000 times g for 5 min, and the total protein concentration was estimated using a micro-Bradford assay (Bio-Rad Laboratories Ltd., Hemel Hempstead, UK). To confirm that equal quantities of cell protein were used for CAT assays, 1 µg of total cell protein was separated by SDS-PAGE, and the gel was stained with silver. The CAT reaction was done with 10 µg of total cell protein and carried out for 1 h at 37 °C in a 150-µl reaction mixture containing 2 µl of [^14C]chloramphenicol (DuPont NEN Products, Stevenage, UK), 0.53 mM acetyl coenzyme A, 0.25 M Tris-Cl, pH 7.8. After chloramphenicol extraction with ethyl acetate, acetylated [^14C]chloramphenicol was separated from the nonacetylated form by thin-layer chromatography. CAT activity was determined by measuring the level of the acetylated chloramphenicol, using storage phosphor imaging plates and a Fujix Bas 2000 bioimaging analyzer.

Electrophoretic Mobility Shift Assays

Primary cultures of mammary epithelial cells from pregnant non-transgenic ICR mice were harvested by trypsinization either at the end of the initial plating period in growth medium or following a switch for 1, 2, or 3 days to differentiation medium with or without prolactin. Cell pellets were snap frozen in liquid N(2) and nuclear extracts prepared as described(26) . The total protein concentration was estimated by the Pierce BCA protein assay (Pierce and Warriner (UK) Ltd., Chester, UK), and equal quantities of protein were added to end-labeled double-stranded oligodeoxynucleotides for electrophoretic mobility shift assays. The oligodeoxynucleotides used were the recognition motifs for Stat5 STM site (5`-GATTCCGGGAACCGCGT), NF-1 (5`-GATCTTTGGCTTGAAGCCAATA), and Sp-1 (5`-ATTCGATCGGGGCGGGGCGAG). In some assays, the nuclear extracts were preincubated overnight at 4 °C with antibodies to Stat5(27) , Stat1 (E23, Santa Cruz Biotechnology, Inc., Santa Cruz, CA), or phosphotyrosine (PY20, Santa Cruz) before addition of DNA.


RESULTS

In order to dissect the mechanism of basement membrane control of milk protein expression, we used primary and first passage cultures of mammary epithelial cells. This enabled us to examine the signaling requirements for cells in culture that were as closely related as possible to those for cells in vivo. Initially we studied the activity of a transgenic ovine BLG promoter using a well established culture model for mammary differentiation(1, 2, 4, 5) .

In transgenic mice, the BLG promoter sequence is strongly active in mammary gland during pregnancy and lactation(20) . To assess whether the activity of this promoter is regulated by cell-matrix interactions, mammary epithelial cells from a series of transgenic mice expressing BLG constructs (Fig. 1) were plated on plastic dishes or on a reconstituted basement membrane extract from the EHS tumor and cultured under differentiation conditions with lactogenic hormones. After 3 days, the cultures were pulse-labeled with [S]methionine, and cell lysates were prepared by detergent extraction(5, 23) . Total lysates of mammary epithelial cells isolated from pregnant BLGDeltaDp/39 mice showed that although BLG was synthesized by cells cultured both on plastic and EHS matrix, its expression was up-regulated dramatically by basement membrane (Fig. 2A). Quantitative measurements indicated a 3.7-fold increase of BLG expression on EHS matrix over plastic. Immune precipitation experiments showed that endogenous mouse milk protein synthesis was also up-regulated by this matrix (Fig. 2B), as expected from earlier studies(1, 2, 4, 5) . Very similar results were obtained from cultures of BLG.SX/45 mice, which contain 4.3 kb of the BLG promoter sequence rather than just the 406 bp of BLGDeltaDp/39. Thus, the expression of a transgenic ovine BLG gene in mammary epithelial cells is under the control of ECM.


Figure 2: Basement membrane- and laminin-dependent control of BLG promoter activity. Mammary glands from midpregnant BLGDeltaDp/39 or BCDeltaDp/188 mice were digested and the epithelial cells established in culture. A and B show that expression of BLG was dependent on the type of substratum that the cells encounter. First passage BLGDeltaDp/39 cells were plated on plastic (P) or on a reconstituted basement membrane from the EHS tumor (E) and cultured for 3 days with the lactogenic hormones, prolactin, hydrocortisone, and insulin. At the end of the culture period, the cells were pulse-labeled with [S]methionine for 27 min, the medium was collected, and the cells were extracted with radioimmune precipitation buffer. Aliquots of cell lysate representing equal amounts of newly synthesized protein were (A) separated by 15% reducing SDS-PAGE and (B) immune precipitated using an antibody specific for mouse milk proteins, but not ovine BLG, before separation by SDS-PAGE. The band designated BLG was confirmed by immune precipitation with a BLG-specific antibody (not shown). No proteins of this size were detected in radiolabeled whole cell extracts from non-transgenic mouse cultures. Similar results to those shown were obtained from BLGDeltaDp/46 and BLG.SX/45 mice. C shows that purified laminin-1 induced expression of BLG. For this assay, first passage BLGDeltaDp/39 cells were seeded on coverslips and then treated with 200 µg/ml soluble ECM proteins diluted into the culture medium for 4 days in the presence of lactogenic hormones(5) . Controls received hormones but no ECM protein. Alternatively, cells were plated on top of EHS gels. At the end of the culture period, cells were pulse-labeled with [S]methionine for 75 min and extracted, and equal aliquots of newly synthesized total cell protein were separated by SDS-PAGE. Shown is the region of the gel containing BLG. D shows that the 406-bp promoter of the BLG gene itself contains matrix-dependent control elements. Mammary epithelial cells from pregnant BCDeltaDp/188 mice were either plated directly on plastic or EHS matrix (P and E; leftpanel) or were cultured on collagen before being replated as first passage cultures on plastic, collagen I, or EHS matrix (P, C, E; rightpanel). After 4 days in the presence of lactogenic hormones, cells were lysed and the activity of CAT enzyme was measured. CAT enzyme activity in the EHS cultures was increased 3.4-fold over plastic in primary cells and 2.9-fold over plastic in first passage cells.



We have shown that the basement membrane ligand responsible for triggering beta-casein transcription in mammary epithelial cells is laminin-1(5) . We therefore examined whether laminin-1 could also activate BLG transcription in mammary cultures derived from BLGDeltaDp/39 transgenic mice. Using an assay that we developed previously(5) , first passage cells were plated on coverslips and treated for 4 days with 200 µg/ml purified laminin-1 (19) or complete basement membrane matrix diluted into the culture medium, together with lactogenic hormones. The rate of protein synthesis was examined by pulse-labeling the cultures, followed by detergent extraction and analysis by SDS-PAGE. As above, the cells cultured on EHS matrix expressed high levels of transgenic BLG protein (Fig. 2C). We also found that the cells treated with laminin-1 expressed high levels of BLG, whereas control cultures treated with no exogenous ECM proteins expressed barely detectable amounts of BLG. Similar levels of BLG synthesis to those in the laminin-treated cells were seen in cultures exposed to the complete basement membrane matrix diluted into the medium. These results indicate that an individual, highly purified basement membrane component can induce transcriptional activation from the BLG promoter.

To demonstrate that the matrix control elements are contained within the proximal 406-bp promoter region rather than in sequences either further upstream or in the 3`-flanking region of the BLG gene or in the BLG coding region, mammary cultures were prepared from BCDeltaDp/188 transgenic mice^2 expressing the 406-bp promoter linked to the chloramphenicol acetyltransferase reporter gene (Fig. 1). Primary and first passage cells were cultured on tissue culture plastic, a thin layer of collagen I, or EHS matrix in the presence of lactogenic hormones (Fig. 2D). When cell extracts were analyzed using a CAT assay, we found that CAT enzyme activity was increased by 2.9-3.4-fold in cells cultured on the basement membrane, a similar increase to that of BLG protein in cells from BLGDeltaDp/39 mice.

Together, these experiments show that positively acting, basement membrane-dependent transcription control elements are contained within the proximal 406 bp of the BLG promoter and that these elements can be activated in cells treated with purified laminin-1.

The BLG promoter contains three DNA recognition sequences for the transcription factor, Stat5 (also known as mammary gland factor (11, 12) or milk protein binding factor(26) ). Stat5 is expressed in pregnant and lactating mammary gland (28) and binds -interferon activation site (GAS)-related DNA sequence elements(29) . Since the GAS motifs bound by Stat5 are required for maximum BLG promoter function in vivo(22) , we asked whether they were also required for its activity in culture. Dinucleotide sequences within the three GAS motifs in the proximal 406 bp of the BLG promoter were mutated to abolish Stat5 binding activity, and mice that contained multiple copies of this transgene were produced. In mammary cultures prepared from the resulting BLG-SAA transgenic mice (Fig. 1), low levels of BLG were transcribed from the mutant promoter, but there was no increased synthesis of BLG in cells cultured on EHS matrix (Fig. 3, A and B). This result contrasted with that for endogenous beta-casein, which was induced to a similar extent by the EHS matrix, both in cultures from BLGDeltaDp/39 and BLG-SAA transgenic mice harboring the wild type or mutant BLG promoter and in cultures from BCDeltaDp/188 mice expressing the CAT reporter gene (Fig. 3, A and C). These results confirm previous conclusions that Stat5 binding sites within the BLG promoter are required for a high level of activity(22, 29) . Our observation that BLG expression was not completely abrogated in the BLG-SAA cultures indicates that additional matrix-independent factors have a role in transcription from this promoter. However, since there was no increased expression of BLG in cells cultured on the basement membrane matrix, our results suggested strongly that Stat5 itself was necessary for the matrix-dependent control of expression.


Figure 3: Requirement of Stat5 binding sites for activation of the BLG promoter by basement membrane. First passage cultures were prepared from BLGDeltaDp/46 and BLG-SAA transgenic mice and analyzed as described in Fig. 2. A shows a gel of total lysates from cells cultured for 4 days with lactogenic hormones on plastic (P), collagen I (C), or EHS matrix (E) and then pulse labeled for 45 min with [S]methionine. A similar gel was exposed to a storage phosphor imaging plate, and the radioactivity in the BLG and beta-casein bands was determined. After normalizing to the total radioactivity in each lane, the levels of BLG (B) and beta-casein (C) were determined. EHS matrix increased the activity of the wild type (BLGDeltaDp/46) promoter by 2.6-fold over plastic but had virtually no effect on the activity of the mutant (BLG-SAA) promoter. For the quantitative analysis, we also included data from cell extracts of BCDeltaDp/188 cultures prepared at the same time, where no proteins corresponding to BLG were detected. In contrast to the results for BLG, the increase in endogenous beta-casein expression was similar for each of the three transgenic lines.



We therefore examined the activity of Stat5 directly, in cells cultured on the different substrata in the presence or absence of prolactin. Cells from non-transgenic mice were cultured on plastic, collagen I, or EHS matrix and then harvested, and nuclear extracts were prepared(26) . DNA electrophoretic mobility shift assays were performed using the oligodeoxynucleotide sequence corresponding to the highest affinity Stat5 binding site in the BLG promoter(26) . Stat5 DNA binding activity was strongly induced in cells cultured on basement membrane matrix providing prolactin was present (Fig. 4A), and a similar DNA binding activity was present in extracts of whole mammary gland tissue (Fig. 4B). However, prolactin was unable to induce Stat5 activity in the absence of basement membrane.


Figure 4: Matrix dependence of transcription factor activity. A, primary mammary epithelial cells from non-transgenic midpregnant mice were cultured on plastic (P), collagen I (C), or EHS matrix (E) for 2 days in serum-containing medium. The cultures were washed, and the medium was changed to differentiation medium containing lactogenic hormones with or without prolactin for 0, 2, or 3 days. The cells were then harvested and equal quantities of cell protein were used for electrophoretic mobility shift assays. The DNA oligodeoxynucleotides used were the recognition motifs for Stat5, NF-I, and SP1. In the control lanes (Co), an additional extract from mammary gland was included for the Stat5 assay, and partially purified NF-I protein was included for the NF-I assay. B, equal quantities of cell protein from nuclear extracts of mammary gland or from the EHS sample prepared above (2 days in differentiation medium) were used for electromobility shift assays with the Stat5 probe. Antibodies, as indicated, were incubated with nuclear extract before addition of the probe. PY, phosphotyrosine.



To confirm that gel retardation was due to binding of Stat5 rather than other Stat factors, competition experiments were carried out in the presence of function-blocking anti-Stat antibodies. Complex formation was abolished by an anti-Stat5 antibody but not by antibodies specific for Stat1 (Fig. 4B) or for Stat2, -3, -4, and -6 (not shown). In addition, Stat5 gel shifts of mammary cell and tissue lysates were substantially blocked by anti-phosphotyrosine antibodies (Fig. 4B), confirming previous studies showing that phosphorylated tyrosine residues on Stat5 are required for its DNA binding activity(12) .

As controls, the DNA binding activity of Sp1 and NF-I transcription factors in these nuclear extracts were also determined. Sp1 was more active in cells cultured on plastic or collagen I substrata, whereas NF-I was more active in the EHS cultures, but this was not dependent on prolactin (Fig. 4A).

Together, our data show that the activities of transcription factors in mammary epithelial cells are regulated differentially by the type of substratum the cell encounters and that Stat5 only binds its cognate DNA sequence in cells that are cultured on a basement membrane.


DISCUSSION

It has been known for some time that expression of tissue-specific milk protein genes in mouse mammary gland requires cell interactions with basement membrane(1, 2, 3) . The milk-producing cells of alveoli interact with a laminin-rich basement membrane in vivo. Culture studies have demonstrated that this association with basement membrane provides signals for milk protein synthesis that are mediated through integrins (4) and derived from the ECM component laminin(5) . These locally acting signals operate together with lactogenic hormones, resulting in transcriptional activation of milk protein promoters (24, 30) via a mechanism that has not yet been elucidated.

In this work we have taken the problem one step back from the level of the promoter and shown that the DNA binding activity of a Stat transcription factor essential for milk protein transcription is controlled by cell-matrix interactions. This conclusion is based on a combination of studies with (i) cultures from transgenic mice, which showed that the BLG promoter was responsive to basement membrane signals but only if Stat5 DNA recognition motifs were intact and (ii) nuclear extracts of cultured cells, showing that the DNA binding activity of Stat5 required signals from an appropriate ECM. The type of matrix able to activate Stat5 was specific since cells cultured on collagen I had low levels of BLG promoter function and no detectable Stat5 DNA binding activity. Instead, the activation signal was contained within a basement membrane matrix and acted coordinately with prolactin.

The initial response to a large class of ligands including prolactin is the rapid activation of gene transcription mediated by Stat factors. Engagement of receptor triggers a cascade of tyrosine phosphorylation events resulting in transcriptional activation by Stats(13, 14, 15) . In COS and Chinese hamster ovary cells, which do not normally synthesize either an endogenous prolactin receptor or Stat5, prolactin can induce de novo transcription from a transfected casein promoter once its receptor and Stat5 are ectopically expressed(11, 12) . However, these minimal requirements for casein promoter activity are not sufficient in mammary gland since prolactin does not induce transcriptional activation of the beta-casein gene or high levels of BLG expression in mammary cells cultured on plastic or collagen I. This implies that tissue-specific gene expression in the natural context is under complex, multifactorial control.

Two lines of evidence show that the appropriate signaling components are present in mammary epithelial cells cultured in the absence of suitable ECM cues. First, cells plated on plastic synthesize functional prolactin receptors, since the mRNA for interferon-regulated factor-1 is induced under this culture condition in response to prolactin. (^3)Second, both Jak2 and Stat5 proteins are present in mammary cells cultured on plastic or collagen I, and their levels are comparable with those in cells cultured on basement membrane matrix. (^4)The lack of Stat5 activity may therefore indicate the existence of additional regulatory factors in differentiating mammary cells. For example, serine phosphorylation is required for the formation of active Stat3 homodimers(32) ; in addition to the Jak2 phosphorylation site on residue 694, Stat5 also contains a consensus site for mitogen-activated protein kinase. This enzyme is activated through cooperative signaling between insulin and ECM(18) , although it is known that insulin signals themselves are not required for prolactin-mediated activation of Stat5 (33) . Alternatively, tyrosine-specific protein phosphatases, which are known to modulate the activity of the erythropoietin receptor(34) , may have a role in controlling some downstream effects of the prolactin receptor.

Our experiments additionally suggest that there are at least two tiers of matrix-dependent regulation at the transcription factor level. First, increased NF-I and decreased Sp1 activity in cells cultured on a basement membrane may reflect a hormone-independent induction of the differentiated state involving cell interactions with the type of ECM that mammary cells encounter in vivo. This control might be mediated via mechanochemical signals from cell-matrix interactions(35, 36, 37) , or alternatively, it could be transmitted through conventional signaling pathways initiated by membrane-associated kinases such as pp125(38) and/or GTPases such as Rho and Rac(39) . A second level of regulation occurs through a coordinate basement membrane- and hormone-dependent triggering of Stat5 function, which directly controls transcription from milk protein promoters.

Several milk protein gene control regions, including the 406-bp BLG promoter(26) , the beta-casein proximal promoter and its enhancer element BCE1(30) , and the whey acidic protein promotor(31) , contain potential recognition sequences for Stat5. Since all of these genes are controlled by ECM, we propose that the matrix-dependent activation of Stat5 provides an essential contribution to the mammary differentiation program.

In conclusion, this study suggests one signaling mechanism to explain previous observations in the mammary system that implicate ECM in the control of differentiation(1, 2, 3, 4, 5) . We have demonstrated that transcription from the BLG promoter requires mammary cells to interact with a basement membrane and that ECM and lactogenic hormones cooperate in the regulation of Stat5 transcription factor activity. To our knowledge, this is the first demonstration that the function of a Stat family member is dependent on signals other than cytokines/growth factors. In the light of recent data showing that cell-matrix interactions also control mitogen-activated protein kinase and insulin receptor substrate-1 activity, our findings now reveal a related mechanism by which extracellular matrix regulates cell phenotype. It is known that proliferation of normal mammalian cells requires not just growth factors but also ECM proteins(40, 41) , and recent studies have suggested that other fundamental processes such as cell survival are dependent on matrix(21, 42) . (^5)Thus, together these studies point to a general control principle involving cross-talk between cytokine- and matrix-mediated signaling pathways.


FOOTNOTES

*
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§
Wellcome Senior Research Fellow in Basic Biomedical Science. To whom correspondence should be addressed. Tel.: 44 161 275 5626; Fax: 44 161 275 3915.

Supported by Wellcome Trust Grant 040944.

**
Supported by the Biotechnology and Biological Sciences Research Council Stem Cell Molecular Biology Programme.

§§
Biotechnology and Biological Sciences Research Council postdoctoral fellow.

(^1)
The abbreviations used are: ECM, extracellular matrix; BLG, beta-lactoglobulin; PBS, phosphate-buffered saline; CAT, chloramphenicol acetyltransferase; EHS, Engelbreth-Holm-Swarm; GAS, -interferon activation site; DMEM, Dulbecco's modified Eagle's medium; PAGE, polyacrylamide gel electrophoresis; kb, kilobase(s); bp, base pair(s).

(^2)
J. Webster, R. M. Wallace, A. J. Clark, and C. B. Whitelaw, manuscript in preparation.

(^3)
J. Ashkenas, M. Bissell, and Z. Werb, personal communication.

(^4)
G. M. Edwards and C. H. Streuli, unpublished data.

(^5)
S. Pullan, J. Wilson, A. Metcalfe, G. M. Edwards, N. Goberdhan, J. Tilly, J. A. Hickman, C. Dive, and C. H. Streuli, submitted for publication.


ACKNOWLEDGEMENTS

Purified mouse laminin-1 was kindly provided by Dr. Peter Yurchenco, Robert Wood Johnson Medical School, Piscataway, NJ. We are indebted to Drs. David Garrod, John Hickman, Martin Humphries, and Chris Reilly for helpful suggestions and critical review of the manuscript. C. J. W. would like to thank Dr. Mina Bissell for help in the preliminary stages of this work.


REFERENCES

  1. Li, M. L., Aggeler, J., Farson, D. A., Hatier, C., Hassell, J., and Bissell, M. J. (1987) Proc. Natl. Acad. Sci. U. S. A. 84,136-140 [Abstract]
  2. Barcellos-Hoff, M. H., Aggeler, J., Ram, T. G., and Bissell, M. J. (1989) Development 105,223-235 [Abstract]
  3. Streuli, C. H. (1995) in The Laminins (Ekblom, P., ed) Harwood Academic Publishers GmbH, Chur, Switzerland, in press
  4. Streuli, C. H., Bailey, N., and Bissell, M. J. (1991) J. Cell Biol. 115,1383-1395 [Abstract]
  5. Streuli, C. H., Schmidhauser, C., Bailey, N., Yurchenco, P., Skubitz, A. P. N., Roskelley, C., and Bissell, M. J. (1995) J. Cell Biol. 129,591-603 [Abstract]
  6. Campbell, G. S., Argetsinger, L. S., Ihle, J. N., Kelly, P. A., Rillema, J. A., and Cartersu, C. (1994) Proc. Natl. Acad. Sci. U. S. A. 91,5232-5236 [Abstract]
  7. David, M., Petricoin, E. F., Igarashi, K., Feldman, G. M., Finbloom, D. S., and Larner, A. C. (1994) Proc. Natl. Acad. Sci. U. S. A. 91,7174-7178 [Abstract]
  8. Dusanter-fourt, I., Muller, O., Ziemiecki, A., Mayeux, P., Drucker, B., Djiane, J., Wilks, A., Harpur, A. G., Fischer, S., and Gisselbrecht, S. (1994) EMBO J. 13,2583-2591 [Abstract]
  9. Gilmour, K. C., and Reich, N. C. (1994) Proc. Natl. Acad. Sci. U. S. A. 91,6850-6854 [Abstract]
  10. Rui, H., Kirken, R. A., and Farrar, W. L. (1994) J. Biol. Chem. 269,5364-5368 [Abstract/Free Full Text]
  11. Wakao, H., Gouilleux, F., and Groner, B. (1994) EMBO J. 13,2182-2191 [Abstract]
  12. Gouilleux, F., Wakao, H., Mundt, M., and Groner, B. (1994) EMBO J. 13,4361-4369 [Abstract]
  13. Briscoe, J., Guschin, D., and Muller, M. (1994) Curr. Biol. 4,1033-1305 [Medline] [Order article via Infotrieve]
  14. Darnell, J. E., Kerr, I. M., and Stark, G. R. (1994) Science 264,1415-1421 [Medline] [Order article via Infotrieve]
  15. Ihle, J. N., and Kerr, I. M. (1995) Trends Genet. 11,69-74 [CrossRef][Medline] [Order article via Infotrieve]
  16. Chen, Q., Kinch, M. S., Lin, T. H., Burridge, K., and Juliano, R. L. (1994) J. Biol. Chem. 269,26602-26605 [Abstract/Free Full Text]
  17. Schlaepfer, D. D., Hanks, S. K., Hunter, T., and van der Geer, P. (1994) Nature 372,786-791 [Medline] [Order article via Infotrieve]
  18. Vuori, K., and Rouslahti, E. (1994) Science 266,1576-1578 [Medline] [Order article via Infotrieve]
  19. Yurchenco, P. D., Cheng, Y.-S., and Colognato, H. (1992) J. Cell Biol. 117,1119-1133 [Abstract]
  20. Whitelaw, C. B., Harris, S., McClenaghan, M., Simons, J. P., and Clark, A. J. (1992) Biochem. J. 286,31-39 [Medline] [Order article via Infotrieve]
  21. Boudreau, N., Sympson, C. J., Werb, Z., and Bissell, M. J. (1995) Science 267,891-893 [Medline] [Order article via Infotrieve]
  22. Burdon, T. G., Maitland, K. A., Clark, J., Wallace, R., and Watson, C. J. (1994) Mol. Endocrinol. 8,1528-1536 [Abstract]
  23. Streuli, C. H., and Bissell, M. J. (1990) J. Cell Biol. 110,1405-1415 [Abstract]
  24. Schmidhauser, C., Casperson, G. F., Myers, C. A., Sanzo, K. T., Bolten, S., and Bissell, M. J. (1992) Mol. Biol. Cell 3,699-709 [Abstract]
  25. Streuli, C. H., Schmidhauser, C., Kobrin, M., Bissell, M. J., and Derynck, R. (1993) J. Cell Biol. 120,253-260 [Abstract]
  26. Watson, C. J., Gordon, K. E., Robertson, M., and Clark, A. J. (1991) Nucleic Acids Res. 19,6603-6610 [Abstract]
  27. Azam, M., Erdjument-Bromage, H., Kreider, B. L., Xia, M., Quelle, F., Basu, R., Saris, C., Tempst, P., Ihle, J. N., and Schindler, C. (1995) EMBO J. 14,1402-1411 [Abstract]
  28. Schmitt-Ney, M., Happ, B., Ball, R. K., and Groner, B. (1992) Proc. Natl. Acad. Sci. U. S. A. 89,3130-3134 [Abstract]
  29. Burdon, T. G., Demmer, J., Clark, A. J., and Watson, C. J. (1994) FEBS Lett. 350,177-182 [CrossRef][Medline] [Order article via Infotrieve]
  30. Schmidhauser, C., Bissell, M. J., Myers, C. A., and Casperson, G. F. (1990) Proc. Natl. Acad. Sci. U. S. A. 87,9118-9122 [Abstract]
  31. Li, S., and Rosen, J. M. (1995) Mol. Cell. Biol. 15,2063-2070 [Abstract]
  32. Zhang, X., Blenis, J., Li, H.-C., Schindler, C., and Chen-Kiang, S. (1995) Science 267,1990-1994 [Medline] [Order article via Infotrieve]
  33. Welte, T., Garimorth, K., Philipp, S., and Doppler, W. (1994) Mol. Endocrinol. 8,1091-1102 [Abstract]
  34. Klingmuller, U., Lorenz, U., Cantley, L. C., Neel, B. G., and Lodish, H. F. (1995) Cell 80,729-738 [Medline] [Order article via Infotrieve]
  35. Bissell, M. J., Hall, H. G., and Parry, G. (1982) J. Theor. Biol. 99,31-68 [Medline] [Order article via Infotrieve]
  36. Wang, N., Butler, J. P., and Ingber, D. E. (1993) Science 260,1124-1127 [Medline] [Order article via Infotrieve]
  37. Roskelley, C. D., Desprez, P. Y., and Bissell, M. J. (1994) Proc. Natl. Acad. Sci. U. S. A. 91,12378-12382 [Abstract/Free Full Text]
  38. Schaller, M. D., and Parsons, J. T. (1994) Curr. Opin. Cell Biol. 6,705-710 [Medline] [Order article via Infotrieve]
  39. Nobes, C. D., and Hall, A. (1995) Cell 81,53-62 [Medline] [Order article via Infotrieve]
  40. Schwartz, M. A. (1992) Trends Cell Biol. 2,304-308
  41. Guadagno, T. M., Ohtsubo, M., Roberts, J. M., and Assoian, R. K. (1993) Science 262,1572-1575 [Medline] [Order article via Infotrieve]
  42. Frisch, S. M., and Francis, H. (1994) J. Cell Biol. 124, 619-626 [Abstract]

©1995 by The American Society for Biochemistry and Molecular Biology, Inc.